Categories Consumer, Earnings Calls

McDonald’s Corp. (MCD) Q4 2020 Earnings Call

McDonald’s Corp. (NYSE: MCD) Q4 2020 earnings call dated Jan. 28, 2021

Corporate Participants:

Mike Cieplak — Corporate Vice President, Investor Relations Officer

Chris Kempczinski — President and Chief Executive Officer

Kevin Ozan — Executive Vice President and Chief Financial Officer

Analysts:

John Glass — Morgan Stanley — Analyst

Eric Gonzalez — KeyBanc — Analyst

David Tarantino — Baird — Analyst

Dennis Geiger — UBS — Analyst

David Palmer — Evercore — Analyst

Jon Tower — Wells Fargo — Analyst

Chris Carril — RBC — Analyst

Jared Garber — Goldman Sachs — Analyst

John Ivankoe — JPMorgan — Analyst

Andrew Charles — Cowen — Analyst

Jeff Bernstein — Barclays — Analyst

Lauren Silberman — Credit Suisse — Analyst

Greg Francfort — Bank of America Merrill Lynch — Analyst

_________
To read the full earnings call transcript, click here

 

Most Popular

Context Therapeutics: Another clinical-stage oncology research firm to go public soon

The US primary markets seem to be having a record-breaking start to the year, with over $171 billion raised in the first half of 2021 compared to $168 billion for

Biogen (BIIB) Stock: Does FDA nod for Aduhelm offer a buying opportunity?

The pharmaceutical industry has been witnessing hectic activity for some time, with most drug makers either channelizing their resources for vaccine development or engaging in COVID care programs. Biotechnology giant

IPO News: Monte Rosa Therapeutics will go public this week, here are a few things to know

Biotechnology company Monte Rosa Therapeutics is slated to go public this week. In a pandemic-ridden world, this industry is expanding at a healthy pace. The global biotechnology market is estimated

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top